Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis

A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m(2) on day 1 and 8, plus capecitabine 1000 mg/m(2) bid for 14 consecutive days every 3 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Valerio, Maria Rosaria, Spadaro, Pietro, Arcanà, Concetta, Borsellino, Nicolò, Cipolla, Calogero, Vigneri, Paolo, Piazza, Dario, Gebbia, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610004/
https://www.ncbi.nlm.nih.gov/pubmed/34840807
http://dx.doi.org/10.2144/fsoa-2020-0095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610004/
https://www.ncbi.nlm.nih.gov/pubmed/34840807
http://dx.doi.org/10.2144/fsoa-2020-0095

Ejemplares similares